AbbVie is looking for a Director of Oncology Market Access Strategy. This position is responsible for market access marketing leadership for Emrelis (telisotuzumab vedotin), an antibody-drug conjugate approved for second-line, c-Met expressing non-squamous non-small cell lung cancer (NSCLC) accompanied by a companion diagnostic for patient selection. Emrelis represents AbbVie’s first oncology solid tumor launch, a key strategic priority for the enterprise, and is in dynamic growth mode.
The Marketing Director will develop strategy and tactics across all payer channels (e.g. Commercial, Medicare, Medicaid, VA, etc). Lead strategic alignment with the Emrelis Integrated Brand Team, developing Market Access strategies with stakeholders in the Oncology commercial organization and US Medical Affairs. As the first AbbVie-led solid tumor and biomarker driven launch in oncology, the Director will bring relevant launch expertise and articulate strategy. The Director will leverage data, analytics and strong strategic mind-set in all aspects of running the marketing component of the business. Throughout their work, the director will provide positive leadership and foster alignment with the broader US Market Access organization.
Key Responsibilities Include:
Discover exciting opportunities in biotech and life sciences. Join innovative companies that are advancing healthcare through cutting-edge research and technology.
Interested in building your career at AbbVie? Get future opportunities sent straight to your email.
Create AlertDiscover similar positions that might interest you
AbbVie
AbbVie
AbbVie
AbbVie
AbbVie
AbbVie